BLOG / 🇺🇸 United States · · daily

USA Insider Trading Pulse — October 21, 2026

USA Insider Trading Pulse

By Gunpowder Editorial ·

50 high priority 50 total filings analysed

Executive Summary

Across 50 Form 4 insider filings dated 2026-10-21, the activity is dominated by routine equity compensation (awards, deferred compensation credits, tax withholdings) and a cluster of sales, most of them flagged as Rule 10b5-1 plan trades, which typically signal pre-scheduled diversification rather than discretionary bearishness.

Notable open-market purchases came from a small-cap CEO (OBOOK Holdings, ~$52K at $4.27), a director at Veraxa Biotech (~$32.7K at $1.09), a director at Nebius Group (~$24.9K across two lots), and a 10% holder, Saba Capital, accumulating positions in Ellsworth Growth & Income Fund and BNY Mellon Strategic Municipals. Heavy selling clustered in high-multiple software and internet names: Pinterest (Silbermann ~$1.08M, Rajaram ~$24K), Gitlab (Sijbrandij ~$3.9M after a 73,459-share sale), HubSpot (Halligan ~$2.04M), Ibotta (CEO Leach ~$1.08M after option exercises), and Paylocity (Sarowitz ~$978K). Sea Ltd insiders sold more than $500K across two executives, and Castle Biosciences' CEO sold roughly $460K across three lots. Several filings carry no period-over-period, forward-looking, capital-allocation, or ratio data, so this digest is limited to transaction-level intelligence; the cumulative dollar value of disclosed sales is material, but the signal is weaker than headline totals suggest once plan-based trades are separated out.

Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →

Filing types in this digest: Form 4

Tracking the trend? Catch up on the prior USA Insider Trading Pulse digest from October 20, 2026.

Investment Signals (11)

  • OBOOK Holdings Inc. ↓ (BULLISH)
    ▲

    CEO Wang Chun Kai bought 12,192 Class A shares at $4.27 (~$52K), now holding 3,137,000 shares; a discretionary open-market purchase by the CEO of a micro-cap

  • Veraxa Biotech Holding AG ↓ (BULLISH)
    ▲

    Director Ziegler Christoph Samuel bought 30,000 ordinary shares at $1.09 (~$32.7K), lifting holdings to 37,932 shares; insider buying at a sub-$1.50 price point

  • Nebius Group N.V. ↓ (BULLISH)
    ▲

    Director Arne Grimme bought 151 shares at $164.62 and 148 at $167.94 (~$24.9K each) under a 10b5-1 plan, a rare insider purchase in a high-multiple AI-infrastructure name

  • Saba Capital Management (10% owner) (BULLISH)
    ▲

    Accumulated 1,830 shares of Ellsworth Growth & Income Fund at $11.39 (~$20.8K), raising its stake to 1,789,855 shares, and bought 7,724 shares of BNY Mellon Strategic Municipals at $5.72 (~$44.2K), reaching 6,436,358 shares; continued accumulation by an activist closed-end fund holder

  • Pinterest, Inc. ↓ (BEARISH)
    ▲

    Director Benjamin Silbermann sold 46,875 Class A shares at $22.56-$22.94 (~$1.08M) after option exercises, retaining 46,875 shares; director Gokul Rajaram sold 1,050 shares at $22.84 (~$24K), retaining 35,146

  • Gitlab Inc. ↓ (BEARISH)
    ▲

    Director Sytse Sijbrandij sold 73,459 Class A shares at $53.13 (~$3.9M) and another 42,741 at $53.52 (~$2.29M), totaling ~$6.2M, though he still holds 12,669,651 shares; the largest single-insider dollar sale in this batch, executed under a 10b5-1 plan

  • HubSpot Inc. ↓ (BEARISH)
    ▲

    Director Brian Halligan sold 8,500 shares at $239.57 (~$2.04M), retaining 59,500 shares, under a 10b5-1 plan; a meaningful reduction in a single director's holdings

  • Ibotta, Inc. ↓ (BEARISH)
    ▲

    CEO Bryan Leach exercised 17,857 options at $5.05 and 5,266 at $5.35, then sold 22,803 shares at $47.29 (~$1.08M); 26 transactions reported and only 169 shares held post-trade, signaling heavy monetization of equity

  • Castle Biosciences Inc. ↓ (BEARISH)
    ▲

    CEO Derek Maetzold sold 8,580, 3,198 and 2,718 shares at $31.91 (~$274K, ~$102K, ~$87K; ~$460K total) and holds 4,114 shares afterward, a near-complete disposal of directly held stock under a 10b5-1 plan

  • Sea Ltd. ↓ (BEARISH)
    ▲

    CCO/GC Wang Yanjun sold 958 shares at $90.29 (~$86.5K) and retains 75,980 shares; CFO Hou Tianyu sold 4,867 shares at $88.54 (~$431K) and 4,348 at $89.16 (~$388K), leaving 35,000 shares, a combined ~$0.9M of selling under 10b5-1 plans

  • Imperial Petroleum Inc. ↓ (BULLISH)
    ▲

    CEO Harry Vafias exercised 117,188 options at $3.20 (~$375K) and holds 3,918,196 shares after the exercise, showing insider equity participation rather than an outright cash-out

Risk Flags (8)

  • Gitlab Inc. / Insider Liquidity↓ [HIGH RISK]
    ▼

    Director Sijbrandij sold ~$6.2M across two lots in one filing window, the largest insider dollar outflow in this batch, though 12.7M shares remain; a large concentrated sale can pressure the stock even when executed under a 10b5-1 plan

  • Ibotta, Inc. / Near-Total Equity Monetization↓ [HIGH RISK]
    ▼

    CEO Bryan Leach holds only 169 shares after selling 22,803 at $47.29 and exercising options through 26 transactions, implying minimal skin-in-the-game alignment with shareholders going forward

  • Pinterest, Inc. / Director Selling Cluster↓ [HIGH RISK]
    ▼

    Two directors sold in the same window (Silbermann ~$1.08M, Rajaram ~$24K) on the heels of option exercises, with Silbermann selling the full 46,875-share exercised block; repeated director liquidation in one sector reads as a negative pattern

  • CastleBiosciences / CEO Position Largely Liquidated [MEDIUM RISK]
    ▼

    CEO Maetzold sold ~$460K over three 10b5-1 transactions and retains only 4,114 directly held shares at $31.91, a sharp reduction in personal exposure

  • Sea Ltd. / Executive Sell-Down↓ [MEDIUM RISK]
    ▼

    CCO and CFO sold a combined ~$0.9M across multiple lots, with the CFO's holdings falling to 35,000 shares; sustained executive selling under plans can compound sentiment weakness

  • HubSpot Inc. / Director Divestment↓ [MEDIUM RISK]
    ▼

    Director Halligan's $2.04M sale of 8,500 shares at $239.57 reduces his position to 59,500 shares; a seven-figure sale by a board member warrants monitoring of board conviction

  • Paylocity Holding Corp. / Large Director Sales↓ [MEDIUM RISK]
    ▼

    Director Steven Sarowitz sold 4,570 shares at $165.99 (~$759K) and 5,875 at $166.47 (~$978K), roughly $1.7M in one filing, though he retains 4.4M shares

  • Star Equity Holdings / Preferred Share Liquidation↓ [LOW RISK]
    ▼

    CEO Jeffrey Eberwein sold 3,000 Series A preferred shares across three trades at $8.99-$9.11, a continued unwind of a senior-security position by the chief executive

Opportunities (7)

  • OBOOK Holdings / CEO Accumulation↓ (OPPORTUNITY)
    ◆

    CEO purchase of 12,192 shares at $4.27 (~$52K) in a micro-cap with no recorded sales, a clean signal of management confidence that can be tracked for follow-on buying

  • Veraxa Biotech / Director Conviction Buy↓ (OPPORTUNITY)
    ◆

    $32.7K open-market purchase at $1.09 by a board member, expanding his holding to 37,932 shares; a low-priced biotech where insider buying can precede catalyst-driven rerating

  • Nebius Group / Repeated Director Purchases at AI-Infrastructure Valuations↓ (OPPORTUNITY)
    ◆

    Two small purchases by director Grimme in the same window (~$24.9K each) at $164-168 while peers sold, a contrarian insider signal in a high-momentum name

  • Saba Capital / Activist Closed-End Fund Accumulation (OPPORTUNITY)
    ◆

    Saba added to both Ellsworth Growth & Income (now 1.79M shares) and BNY Mellon Strategic Municipals (now 6.44M shares), indicating ongoing discount-capture or activist positioning in closed-end funds

  • Imperial Petroleum / Insider Option Exercise Without Sale↓ (OPPORTUNITY)
    ◆

    CEO Vafias exercised 117,188 options at $3.20 and retained 3.9M shares, indicating equity participation rather than monetization in a shipping/petroleum name

  • Erie Indemnity / Broad Director Deferred-Comp Accrual↓ (OPPORTUNITY)
    ◆

    Five directors (Correnti, Datesh, Hagen J., Edwards, Hagen T.) acquired deferred share credits at $245.94, a coordinated board-level accrual that reflects governance alignment rather than selling

  • Beneficient / Director Stock Awards Across the Board↓ (OPPORTUNITY)
    ◆

    Four directors (Cangany, Schnitzer, Hicks, Wendel) received 20K-26K share awards, with Schnitzer and Wendel holding 536,853 and 128,579 shares; board equity compensation at scale aligns directors with holders

Sector Themes (5)

  • Rule 10b5-1 Plan Selling Dominates Tech and Internet Sales (BEARISH)
    ◆

    Of the largest sellers (Gitlab, Pinterest, HubSpot, Ibotta, Sea Ltd, Paylocity, Credo, TD SYNNEX), most trades were executed under pre-arranged 10b5-1 plans, implying scheduled diversification rather than discretionary bearishness; the signal is weaker than headline dollars suggest, and implications are highest where the plan selling coincides with option exercises

  • Director Equity Compensation Is the Majority of Activity (NEUTRAL)
    ◆

    Roughly 20 of 50 filings are award, deferred-comp credit, or tax-withholding transactions (Erie Indemnity, Beneficient, Grupo Cibest, Heron Therapeutics, Tejon Ranch, CVB Financial), so the volume of Form 4s overstates genuine conviction; investors should screen for open-market purchases and large discretionary sales rather than count filings

  • Open-Market Purchases Are Rare and Concentrated in Small Caps (BULLISH)
    ◆

    Only about four to five filings show discretionary buying (OBOOK, Veraxa, Nebius, Saba in closed-end funds), and they are concentrated in micro-caps and closed-end funds rather than large-cap names, which limits their predictive weight but makes them more visible as signals

  • Biotech and Life Sciences Show Mixed Insider Activity (NEUTRAL)
    ◆

    Castle Biosciences (CEO sell), Heron Therapeutics (tax withholding and RSU conversions for CEO and EVPs), Inhibikase (director option award of 310,000) and Veraxa (director purchase) show that biotech insider activity is driven mostly by compensation mechanics, with one genuine open-market buy

  • Closed-End Fund Accumulation by Activist Holder (BULLISH)
    ◆

    Saba Capital appears in two separate closed-end funds with purchases in the same filing window, a pattern consistent with a sustained campaign rather than a one-off trade

Watch List (7)

  • Gitlab Inc.↓
    👁

    Director Sijbrandij's ~$6.2M in sales across two lots after 12.7M retained shares warrants monitoring of further 10b5-1 tranches and any change in post-sale holdings; filing date 2026-10-21

  • Ibotta, Inc.↓
    👁

    CEO Leach's near-zero retained directly held stock (169 shares) after 26 transactions raises the question of whether future option exercises will continue to be sold rather than held; monitor the next Form 4 cadence, filed 2026-10-21

  • Pinterest, Inc.↓
    👁

    Two director sales in one window and the full sale of an exercised 46,875-share block by Silbermann merit tracking whether the 10b5-1 schedule extends into additional quarters; filing date 2026-10-21

  • OBOOK Holdings Inc.↓
    👁

    CEO Wang Chun Kai's discretionary purchase of 12,192 shares is the only open-market buy in this batch from a sole-CEO micro-cap; watch for follow-on purchases as a conviction indicator

  • Veraxa Biotech Holding AG↓
    👁

    Director Ziegler's 30,000-share purchase at $1.09 near penny-stock levels should be tracked for further director buying ahead of any clinical or financing catalyst

  • Saba Capital / Ellsworth Growth & Income and BNY Mellon Strategic Municipals
    👁

    Continued accumulation by a 10% holder in two closed-end funds (1.79M and 6.44M shares) may signal a discount-capture or activist campaign; monitor for additional Form 4 filings or a Schedule 13D

  • Sea Ltd.↓
    👁

    CFO Hou Tianyu's holdings reduced to 35,000 shares after ~$0.9M in combined selling; watch whether executive 10b5-1 sales accelerate into any upcoming reporting or earnings window

Filing Analyses (50)
Sea Ltd 4 negative materiality 2/10

21-10-2026

CCO and GC Wang Yanjun sold 958 Class A ordinary shares at $90.29 (~$86.5K). 9 transactions reported in total. Wang Yanjun holds 75,980 shares after the transaction. Trades executed under a Rule 10b5-1 plan.

  • · CCO and GC Wang Yanjun sold 958 Class A ordinary shares at $90.29 (~$86.5K)
  • · CCO and GC Wang Yanjun sold 25 Class A ordinary shares at $91.77 (~$2.29K)
  • · CCO and GC Wang Yanjun sold 17 Class A ordinary shares at $93.00 (~$1.58K)
  • · CCO and GC Wang Yanjun sold 458 Class A ordinary shares at $80.76 (~$37K)
  • · CCO and GC Wang Yanjun sold 165 Class A ordinary shares at $82.06 (~$13.5K)
  • · CCO and GC Wang Yanjun sold 111 Class A ordinary shares at $82.99 (~$9.21K)
  • · CCO and GC Wang Yanjun sold 60 Class A ordinary shares at $83.86 (~$5.03K)
  • · CCO and GC Wang Yanjun sold 3 Class A ordinary shares at $85.40 (~$256)
Sea Ltd 4 negative materiality 6/10

21-10-2026

CFO Hou Tianyu sold 4,867 Class A ordinary shares at $88.54 (~$431K). 6 transactions reported in total. Hou Tianyu holds 35,000 shares after the transaction. Trades executed under a Rule 10b5-1 plan.

  • · CFO Hou Tianyu sold 4,867 Class A ordinary shares at $88.54 (~$431K)
  • · CFO Hou Tianyu sold 4,348 Class A ordinary shares at $89.16 (~$388K)
  • · CFO Hou Tianyu sold 314 Class A ordinary shares at $90.22 (~$28.3K)
  • · CFO Hou Tianyu sold 237 Class A ordinary shares at $91.60 (~$21.7K)
  • · CFO Hou Tianyu sold 63 Class A ordinary shares at $91.98 (~$5.79K)
  • · CFO Hou Tianyu sold 171 Class A ordinary shares at $93.00 (~$15.9K)
OBOOK HOLDINGS INC. 4 positive materiality 4/10

21-10-2026

Chief Executive Officer WANG CHUN KAI bought 12,192 Class A Common Shares at $4.27 (~$52K). WANG CHUN KAI holds 3,137,000 shares after the transaction.

  • · Chief Executive Officer WANG CHUN KAI bought 12,192 Class A Common Shares at $4.27 (~$52K)
Valens Semiconductor Ltd. 4 negative materiality 2/10

21-10-2026

VP Finance Rozenberg Haine Yael sold 1,458 Ordinary Shares at $1.62 (~$2.36K). Rozenberg Haine Yael holds 135,859 shares after the transaction. Trades executed under a Rule 10b5-1 plan.

  • · VP Finance Rozenberg Haine Yael sold 1,458 Ordinary Shares at $1.62 (~$2.36K)
Grupo Cibest S.A. 4 neutral materiality 3/10

21-10-2026

Director Restrepo Echavarria Luis Fernando was awarded 373.69 Units in Grupo Cibest Equity Securities Fund at $9.88 (~$3.69K).

  • · Director Restrepo Echavarria Luis Fernando was awarded 373.69 Units in Grupo Cibest Equity Securities Fund at $9.88 (~$3.69K)
Grupo Cibest S.A. 4 neutral materiality 3/10

21-10-2026

Director Zapata Zuluaga Nicolas was awarded 457.66 Units in Grupo Cibest Equity Securities Fund at $9.88 (~$4.52K).

  • · Director Zapata Zuluaga Nicolas was awarded 457.66 Units in Grupo Cibest Equity Securities Fund at $9.88 (~$4.52K)
Grupo Cibest S.A. 4 neutral materiality 3/10

21-10-2026

Director Mejia Cardona Andres Felipe was awarded 640.58 Units in Grupo Cibest Equity Securities Fund at $9.88 (~$6.33K).

  • · Director Mejia Cardona Andres Felipe was awarded 640.58 Units in Grupo Cibest Equity Securities Fund at $9.88 (~$6.33K)
Grupo Cibest S.A. 4 neutral materiality 3/10

21-10-2026

Director Toro Valencia Juan Esteban was awarded 441.77 Units in Grupo Cibest Equity Securities Fund at $9.88 (~$4.36K).

  • · Director Toro Valencia Juan Esteban was awarded 441.77 Units in Grupo Cibest Equity Securities Fund at $9.88 (~$4.36K)
Grupo Cibest S.A. 4 neutral materiality 3/10

21-10-2026

Director Jaramillo Mejia Ricardo was awarded 244.62 Units in Grupo Cibest Equity Securities Fund at $9.88 (~$2.42K).

  • · Director Jaramillo Mejia Ricardo was awarded 244.62 Units in Grupo Cibest Equity Securities Fund at $9.88 (~$2.42K)
ERIE INDEMNITY CO 4 neutral materiality 3/10

21-10-2026

Director Correnti Salvatore acquired 18.21 Directors' Deferred Compensation Share Credits at $245.94 (~$4.48K).

  • · Director Correnti Salvatore acquired 18.21 Directors' Deferred Compensation Share Credits at $245.94 (~$4.48K)
HERON THERAPEUTICS, INC. /DE/ 4 neutral materiality 4/10

21-10-2026

EVP, Chief Financial Officer Duarte Ira had withheld for taxes 1,102 Common Stock at $0.36 (~$397). Duarte Ira holds 284,671 shares after the transaction.

  • · EVP, Chief Financial Officer Duarte Ira exercised/converted 3,874 Common Stock
  • · EVP, Chief Financial Officer Duarte Ira had withheld for taxes 1,102 Common Stock at $0.36 (~$397)
  • · EVP, Chief Financial Officer Duarte Ira exercised/converted 3,874 Restricted Stock Units
HERON THERAPEUTICS, INC. /DE/ 4 neutral materiality 4/10

21-10-2026

EVP, Chief Development Officer Forbes William P had withheld for taxes 1,102 Common Stock at $0.36 (~$397). Forbes William P holds 243,945 shares after the transaction.

  • · EVP, Chief Development Officer Forbes William P exercised/converted 3,874 Common Stock
  • · EVP, Chief Development Officer Forbes William P had withheld for taxes 1,102 Common Stock at $0.36 (~$397)
  • · EVP, Chief Development Officer Forbes William P exercised/converted 3,874 Restricted Stock Units
TEJON RANCH CO 4 neutral materiality 3/10

21-10-2026

Director TISCH DANIEL R was awarded 2,023 Common Stock at $16.22 (~$32.8K). TISCH DANIEL R holds 91,784 shares after the transaction.

  • · Director TISCH DANIEL R was awarded 2,023 Common Stock at $16.22 (~$32.8K)
MOOG INC. 4 neutral materiality 5/10

21-10-2026

Director FISHBACK DONALD R gifted 4,200 Class A Common. FISHBACK DONALD R holds 4,200 shares after the transaction.

  • · Director FISHBACK DONALD R gifted 4,200 Class A Common
  • · Director FISHBACK DONALD R gifted 4,200 Class A Common
HERON THERAPEUTICS, INC. /DE/ 4 neutral materiality 5/10

21-10-2026

Chief Executive Officer Collard Craig A had withheld for taxes 3,360 Common Stock at $0.36 (~$1.21K). Collard Craig A holds 866,929 shares after the transaction.

  • · Chief Executive Officer Collard Craig A exercised/converted 13,797 Common Stock
  • · Chief Executive Officer Collard Craig A had withheld for taxes 3,360 Common Stock at $0.36 (~$1.21K)
  • · Chief Executive Officer Collard Craig A exercised/converted 13,797 Restricted Stock Units
ERIE INDEMNITY CO 4 neutral materiality 3/10

21-10-2026

Director Datesh LuAnn acquired 26.469 Directors' Deferred Compensation Share Credits at $245.94 (~$6.51K).

  • · Director Datesh LuAnn acquired 26.469 Directors' Deferred Compensation Share Credits at $245.94 (~$6.51K)
ERIE INDEMNITY CO 4 neutral materiality 3/10

21-10-2026

Director Hagen Jonathan Hirt acquired 103.298 Directors' Deferred Compensation Share Credits at $245.94 (~$25.4K).

  • · Director Hagen Jonathan Hirt acquired 103.298 Directors' Deferred Compensation Share Credits at $245.94 (~$25.4K)
ERIE INDEMNITY CO 4 neutral materiality 3/10

21-10-2026

Director Edwards William David acquired 1.556 Directors' Deferred Compensation Share Credits at $245.94 (~$383).

  • · Director Edwards William David acquired 1.556 Directors' Deferred Compensation Share Credits at $245.94 (~$383)
ERIE INDEMNITY CO 4 neutral materiality 3/10

21-10-2026

Director Hagen Thomas B acquired 88.135 Directors' Deferred Compensation Share Credits at $245.94 (~$21.7K).

  • · Director Hagen Thomas B acquired 88.135 Directors' Deferred Compensation Share Credits at $245.94 (~$21.7K)
CVB FINANCIAL CORP 4 neutral materiality 3/10

21-10-2026

Chief Accounting Officer Laygo Sheryl had withheld for taxes 359 Common Stock at $22.16 (~$7.96K). Laygo Sheryl holds 13,793 shares after the transaction.

  • · Chief Accounting Officer Laygo Sheryl had withheld for taxes 359 Common Stock at $22.16 (~$7.96K)
ELLSWORTH GROWTH & INCOME FUND LTD 4 positive materiality 3/10

21-10-2026

10% owner Saba Capital Management, L.P. bought 1,830 Common Stock at $11.39 (~$20.8K). Saba Capital Management, L.P. holds 1,789,855 shares after the transaction.

  • · 10% owner Saba Capital Management, L.P. bought 1,830 Common Stock at $11.39 (~$20.8K)
Blend Labs, Inc. 4 negative materiality 2/10

21-10-2026

HEAD OF BLEND Ghamsari Nima sold 27,775 Class A Common Stock at $0.92 (~$25.7K). Ghamsari Nima holds 7,750,693 shares after the transaction. Trades executed under a Rule 10b5-1 plan.

  • · HEAD OF BLEND Ghamsari Nima sold 27,775 Class A Common Stock at $0.92 (~$25.7K)
Beneficient 4 neutral materiality 3/10

21-10-2026

Director CANGANY PETER T JR was awarded 25,689 Class A Common Stock. CANGANY PETER T JR holds 404,820 shares after the transaction.

  • · Director CANGANY PETER T JR was awarded 25,689 Class A Common Stock
CASTLE BIOSCIENCES INC 4 negative materiality 6/10

21-10-2026

Pres. & Chief Exec. Officer MAETZOLD DEREK J sold 8,580 Common Stock at $31.91 (~$274K). MAETZOLD DEREK J holds 4,114 shares after the transaction. Trades executed under a Rule 10b5-1 plan.

  • · Pres. & Chief Exec. Officer MAETZOLD DEREK J sold 8,580 Common Stock at $31.91 (~$274K)
  • · Pres. & Chief Exec. Officer MAETZOLD DEREK J sold 3,198 Common Stock at $31.91 (~$102K)
  • · Pres. & Chief Exec. Officer MAETZOLD DEREK J sold 2,718 Common Stock at $31.91 (~$86.7K)
UNIFI INC 4 neutral materiality 2/10

21-10-2026

EVP MOORE BRIAN DAVID disposed of 7 Common Stock at $4.37 (~$30.6). MOORE BRIAN DAVID holds 66,149 shares after the transaction.

  • · EVP MOORE BRIAN DAVID disposed of 7 Common Stock at $4.37 (~$30.6)
Paylocity Holding Corp 4 negative materiality 4/10

21-10-2026

Director Sarowitz Steven I sold 5,875 Common Stock, par value $0.001 at $166.47 (~$978K). Sarowitz Steven I holds 4,414,756 shares after the transaction. Trades executed under a Rule 10b5-1 plan.

  • · Director Sarowitz Steven I sold 4,570 Common Stock, par value $0.001 at $165.99 (~$759K)
  • · Director Sarowitz Steven I sold 5,875 Common Stock, par value $0.001 at $166.47 (~$978K)
Beneficient 4 neutral materiality 3/10

21-10-2026

Director Schnitzer Bruce William was awarded 23,300 Class A Common Stock. Schnitzer Bruce William holds 536,853 shares after the transaction.

  • · Director Schnitzer Bruce William was awarded 23,300 Class A Common Stock
Beneficient 4 neutral materiality 4/10

21-10-2026

Director Hicks Mack H. was awarded 20,910 Class A Common Stock. Hicks Mack H. holds 47,738 shares after the transaction.

  • · Director Hicks Mack H. was awarded 20,910 Class A Common Stock
Beneficient 4 neutral materiality 4/10

21-10-2026

Director Wendel Karen was awarded 25,689 Class A Common Stock. Wendel Karen holds 128,579 shares after the transaction.

  • · Director Wendel Karen was awarded 25,689 Class A Common Stock
AMERICAN PUBLIC EDUCATION INC 4 neutral materiality 4/10

21-10-2026

EVP & Chief Financial Officer Codispoti Edward H had withheld for taxes 689 Common Stock, par value $.01 at $48.56 (~$33.5K). Codispoti Edward H holds 7,788 shares after the transaction.

  • · EVP & Chief Financial Officer Codispoti Edward H had withheld for taxes 689 Common Stock, par value $.01 at $48.56 (~$33.5K)
Pulsenmore Ltd. 4 neutral materiality 5/10

21-10-2026

Chief Commercial Officer Woods David was awarded 6,886 Options to Purchase Ordinary Shares.

  • · Chief Commercial Officer Woods David was awarded 6,886 Options to Purchase Ordinary Shares
HUBSPOT INC 4 negative materiality 6/10

21-10-2026

Director Halligan Brian sold 8,500 Common Stock at $239.57 (~$2.04M). Halligan Brian holds 59,500 shares after the transaction. Trades executed under a Rule 10b5-1 plan.

  • · Director Halligan Brian sold 8,500 Common Stock at $239.57 (~$2.04M)
Imperial Petroleum Inc./Marshall Islands 4 neutral materiality 6/10

21-10-2026

CEO and President Vafias Harry exercised/converted 117,188 Common Stock at $3.20 (~$375K). Vafias Harry holds 3,918,196 shares after the transaction.

  • · CEO and President Vafias Harry exercised/converted 117,188 Common Stock at $3.20 (~$375K)
  • · CEO and President Vafias Harry exercised/converted 117,188 Stock Option (Right to Buy)
Credo Technology Group Holding Ltd 4 negative materiality 5/10

21-10-2026

Pres & Chief Executive Officer Brennan William Joseph sold 3,186 Ordinary Shares at $173.37 (~$552K). 11 transactions reported in total. Brennan William Joseph holds 1,584,164 shares after the transaction. Trades executed under a Rule 10b5-1 plan.

  • · Pres & Chief Executive Officer Brennan William Joseph sold 769 Ordinary Shares at $170.39 (~$131K)
  • · Pres & Chief Executive Officer Brennan William Joseph sold 568 Ordinary Shares at $171.50 (~$97.4K)
  • · Pres & Chief Executive Officer Brennan William Joseph sold 2,694 Ordinary Shares at $172.54 (~$465K)
  • · Pres & Chief Executive Officer Brennan William Joseph sold 3,186 Ordinary Shares at $173.37 (~$552K)
  • · Pres & Chief Executive Officer Brennan William Joseph sold 2,592 Ordinary Shares at $174.50 (~$452K)
  • · Pres & Chief Executive Officer Brennan William Joseph sold 1,624 Ordinary Shares at $175.36 (~$285K)
  • · Pres & Chief Executive Officer Brennan William Joseph sold 1,490 Ordinary Shares at $176.36 (~$263K)
  • · Pres & Chief Executive Officer Brennan William Joseph sold 1,232 Ordinary Shares at $177.44 (~$219K)
Forbright, Inc. 4 neutral materiality 3/10

21-10-2026

Director Sachs Lewis A disposed to the issuer 148,256 Class B Common Stock. Sachs Lewis A holds 3,326,507 shares after the transaction.

  • · Director Sachs Lewis A disposed to the issuer 148,256 Class B Common Stock
  • · Director Sachs Lewis A was awarded 148,256 Class A Common Stock
Direct Digital Holdings, Inc. 4 neutral materiality 5/10

21-10-2026

CFO Diaz Diana P had withheld for taxes 9 Class A Common Stock, par value $0.001 per share at $0.32 (~$2.88). Diaz Diana P holds 178 shares after the transaction.

  • · CFO Diaz Diana P exercised/converted 28 Class A Common Stock, par value $0.001 per share
  • · CFO Diaz Diana P had withheld for taxes 9 Class A Common Stock, par value $0.001 per share at $0.32 (~$2.88)
  • · CFO Diaz Diana P exercised/converted 28 Restricted Stock Units
Veraxa Biotech Holding AG 4 positive materiality 5/10

21-10-2026

Director Ziegler Christoph Samuel bought 30,000 Ordinary Shares at $1.09 (~$32.7K). Ziegler Christoph Samuel holds 37,932 shares after the transaction.

  • · Director Ziegler Christoph Samuel bought 30,000 Ordinary Shares at $1.09 (~$32.7K)
Nebius Group N.V. 4 positive materiality 2/10

21-10-2026

Director Grimme Arne bought 151 Class A Shares at $164.62 (~$24.9K). Grimme Arne holds 6,628 shares after the transaction. Trades executed under a Rule 10b5-1 plan.

  • · Director Grimme Arne bought 151 Class A Shares at $164.62 (~$24.9K)
  • · Director Grimme Arne bought 148 Class A Shares at $167.94 (~$24.9K)
Inhibikase Therapeutics, Inc. 4 neutral materiality 5/10

21-10-2026

Director Wasserman Scott M. was awarded 310,000 Stock Option (Right to Buy).

  • · Director Wasserman Scott M. was awarded 310,000 Stock Option (Right to Buy)
Northwest Natural Holding Co 4 negative materiality 2/10

21-10-2026

Director ANDERSON DAVID HUGO sold 1,500 Common Stock at $48.71 (~$73.1K). ANDERSON DAVID HUGO holds 47,759 shares after the transaction. Trades executed under a Rule 10b5-1 plan.

  • · Director ANDERSON DAVID HUGO sold 1,500 Common Stock at $48.71 (~$73.1K)
BNY MELLON STRATEGIC MUNICIPALS, INC. 4 positive materiality 3/10

21-10-2026

10% owner Saba Capital Management, L.P. bought 7,724 Common Stock at $5.72 (~$44.2K). Saba Capital Management, L.P. holds 6,436,358 shares after the transaction.

  • · 10% owner Saba Capital Management, L.P. bought 7,724 Common Stock at $5.72 (~$44.2K)
Worthington Steel, Inc. 4 neutral materiality 1/10

21-10-2026

Form 4 ownership filing; the structured EDGAR document could not be retrieved for automated parsing.

CarGurus, Inc. 4 neutral materiality 5/10

21-10-2026

CFO and Treasurer Mandel Matthew Charles was awarded 175,083 Class A Common Stock. Mandel Matthew Charles holds 175,083 shares after the transaction.

  • · CFO and Treasurer Mandel Matthew Charles was awarded 175,083 Class A Common Stock
Star Equity Holdings, Inc. 4 negative materiality 3/10

21-10-2026

Chief Executive Officer Eberwein Jeffrey E. sold 1,000 Series A Preferred Stock at $9.11 (~$9.11K). Eberwein Jeffrey E. holds 750,936 shares after the transaction. Trades executed under a Rule 10b5-1 plan.

  • · Chief Executive Officer Eberwein Jeffrey E. sold 1,000 Series A Preferred Stock at $9.11 (~$9.11K)
  • · Chief Executive Officer Eberwein Jeffrey E. sold 1,000 Series A Preferred Stock at $9.10 (~$9.1K)
  • · Chief Executive Officer Eberwein Jeffrey E. sold 1,000 Series A Preferred Stock at $8.99 (~$8.99K)
PINTEREST, INC. 4 negative materiality 7/10

21-10-2026

Director Silbermann Benjamin sold 46,875 Class A Common Stock at $22.94 (~$1.08M). 6 transactions reported in total. Silbermann Benjamin holds 46,875 shares after the transaction. Trades executed under a Rule 10b5-1 plan.

  • · Director Silbermann Benjamin exercised/converted 46,875 Class A Common Stock
  • · Director Silbermann Benjamin sold 46,875 Class A Common Stock at $22.56 (~$1.06M)
  • · Director Silbermann Benjamin exercised/converted 46,875 Class A Common Stock
  • · Director Silbermann Benjamin sold 46,875 Class A Common Stock at $22.94 (~$1.08M)
  • · Director Silbermann Benjamin exercised/converted 46,875 Class B Common Stock
  • · Director Silbermann Benjamin exercised/converted 46,875 Class B Common Stock
PINTEREST, INC. 4 negative materiality 4/10

21-10-2026

Director Rajaram Gokul sold 1,050 Class A Common Stock at $22.84 (~$24K). Rajaram Gokul holds 35,146 shares after the transaction. Trades executed under a Rule 10b5-1 plan.

  • · Director Rajaram Gokul sold 1,050 Class A Common Stock at $22.84 (~$24K)
TD SYNNEX CORP 4 negative materiality 5/10

21-10-2026

President, North America Thompson Reyna sold 814 Common Stock at $248.53 (~$202K). 6 transactions reported in total. Thompson Reyna holds 13,857 shares after the transaction. Trades executed under a Rule 10b5-1 plan.

  • · President, North America Thompson Reyna sold 200 Common Stock at $244.67 (~$48.9K)
  • · President, North America Thompson Reyna sold 619 Common Stock at $247.80 (~$153K)
  • · President, North America Thompson Reyna sold 814 Common Stock at $248.53 (~$202K)
  • · President, North America Thompson Reyna sold 600 Common Stock at $249.47 (~$150K)
  • · President, North America Thompson Reyna sold 100 Common Stock at $250.65 (~$25.1K)
  • · President, North America Thompson Reyna sold 100 Common Stock at $251.11 (~$25.1K)
Xylem Inc. 4 neutral materiality 4/10

21-10-2026

EVP & President, MCS Emmerich Meredith had withheld for taxes 837 Common Stock at $106.35 (~$89K). Emmerich Meredith holds 4,610 shares after the transaction.

  • · EVP & President, MCS Emmerich Meredith had withheld for taxes 837 Common Stock at $106.35 (~$89K)
Ibotta, Inc. 4 negative materiality 7/10

21-10-2026

CEO AND PRESIDENT Leach Bryan sold 22,803 Class A Common Stock at $47.29 (~$1.08M). 26 transactions reported in total. Leach Bryan holds 169 shares after the transaction. Trades executed under a Rule 10b5-1 plan.

  • · CEO AND PRESIDENT Leach Bryan exercised/converted 17,857 Class A Common Stock at $5.05 (~$90.2K)
  • · CEO AND PRESIDENT Leach Bryan exercised/converted 5,266 Class A Common Stock at $5.35 (~$28.2K)
  • · CEO AND PRESIDENT Leach Bryan sold 22,803 Class A Common Stock at $47.29 (~$1.08M)
  • · CEO AND PRESIDENT Leach Bryan sold 320 Class A Common Stock at $47.83 (~$15.3K)
  • · CEO AND PRESIDENT Leach Bryan exercised/converted 4,135 Class A Common Stock
  • · CEO AND PRESIDENT Leach Bryan sold 4,081 Class A Common Stock at $47.29 (~$193K)
  • · CEO AND PRESIDENT Leach Bryan sold 54 Class A Common Stock at $47.82 (~$2.58K)
  • · CEO AND PRESIDENT Leach Bryan exercised/converted 4,135 Class A Common Stock
Gitlab Inc. 4 negative materiality 4/10

21-10-2026

Director Sijbrandij Sytse sold 73,459 Class A Common Stock at $53.13 (~$3.9M). Sijbrandij Sytse holds 12,669,651 shares after the transaction. Trades executed under a Rule 10b5-1 plan.

  • · Director Sijbrandij Sytse sold 73,459 Class A Common Stock at $53.13 (~$3.9M)
  • · Director Sijbrandij Sytse sold 42,741 Class A Common Stock at $53.52 (~$2.29M)

Get daily alerts with 11 investment signals, 8 risk alerts, 7 opportunities and full AI analysis of all 50 filings

Start free trial Browse all digests

$30/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.

More from: USA Insider Trading Pulse

October 19, 2026

USA Insider Trading Pulse — October 19, 2026

October 16, 2026

USA Insider Trading Pulse — October 16, 2026

October 15, 2026

USA Insider Trading Pulse — October 15, 2026

October 14, 2026

USA Insider Trading Pulse — October 14, 2026

🇺🇸 More from United States

View all →

October 21, 2026

US Pre-Market SEC Filings Roundup — October 21, 2026

US Pre-Market SEC Filings Roundup

October 21, 2026

US Merger & Acquisition SEC Filings — October 21, 2026

US Merger & Acquisition SEC Filings

October 20, 2026

US Pre-Market SEC Filings Roundup — October 20, 2026

US Pre-Market SEC Filings Roundup

October 20, 2026

S&P 500 Energy Sector SEC Filings — October 20, 2026

S&P 500 Energy Sector SEC Filings
← All United States digests